Preliminary Financial Results and BusinessUpdate for the Quarter and Year Ended December 31, 2025. Preliminary Financial Results and Business Update for the Quarter and Year Ended December 31, 2025 ... .
... cancers, today announced the pricing of an upsized public offering of 22,500,000 shares of its common stock. The shares of common stock are being sold to the public at a price of $10.00 per share.
In addition, Axogen has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of its common stock at the public offering price, less underwriting discounts and commissions.
Title expert Patrick J. Corbett of Vanguard Research & Title Services, Inc., explains the common mistakes in working with a title company in closing a home... .